Piers Gaunt

2.6k citations
24 papers · 1.8k indexed · 1 hit paper · h-index 11
Topics
Liver Disease Diagnosis and Treatment (5 papers)Lung Cancer Research Studies (5 papers)Sarcoma Diagnosis and Treatment (5 papers)

In The Last Decade

Piers Gaunt

22 papers receiving 1.8k citations

Hit Papers

Liraglutide safety and efficacy in patients with non-alco...2015202620182022201550010001.5k

Peers

Piers Gaunt
Comparison fields: 5 of 84
  • Epidemiology 1.4k
  • Endocrinology, Diabetes and Metabolism 1.1k
  • Molecular Biology 392
  • Hepatology 381
  • Surgery 373
Replace Darren Barton with:
Darren Barton United Kingdom
Tomoaki Nakajima Japan
Geoff Farrell Australia
Shiro Maeyama Japan
Angelo H. Paredes United States
John Willy Haukeland Norway
Rosellina Margherita Mancina Sweden
Joan Hecht United States
Ramy Younes Italy
Abdullah Al‐Osaimi United States
Piers Gaunt relative to Darren Barton United Kingdom Darren Barton's profile →
Citations per field
00.5×1.5×
Darren Barton · 1×
Citations per year

Countries citing papers authored by Piers Gaunt

Since Specialization
Citations

This map shows the geographic impact of Piers Gaunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piers Gaunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piers Gaunt more than expected).

Fields of papers citing papers by Piers Gaunt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piers Gaunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piers Gaunt. The network helps show where Piers Gaunt may publish in the future.

Co-authorship network of co-authors of Piers Gaunt

This figure shows the co-authorship network connecting the top 25 collaborators of Piers Gaunt. A scholar is included among the top collaborators of Piers Gaunt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piers Gaunt. Piers Gaunt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 4
5 5
6 17
7 30
8 10
9 15
10 17
11 17
12 10
13 12
14
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 studybreakdown →
1554
15 3
16 48
17 2
18
Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
1
19 39
20 1

About Piers Gaunt

Piers Gaunt is a scholar working on Otorhinolaryngology, Oncology and Statistics and Probability, having authored 24 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers) and Sarcoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.1k citations), Hepatology (381 citations) and Epidemiology (1.4k citations). Piers Gaunt has collaborated with scholars based in United Kingdom, Ireland and Italy. Frequent co-authors include Rachel M. Brown, Stephen Gough, Philip N. Newsome, Darren Barton, Diana Hull, Jeremy Tomlinson, Matthew J. Armstrong, Deborah Stocken, Stefan G. Hübscher and Kathy Guo. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026